BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29588475)

  • 1. NF-kB2 Genetic Variations are Significantly Associated with Non-Small Cell Lung Cancer Risk and Overall Survival.
    Dimitrakopoulos FD; Antonacopoulou AG; Kottorou AE; Maroussi S; Panagopoulos N; Koukourikou I; Scopa C; Kalofonou M; Koutras A; Makatsoris T; Papadaki H; Dougenis D; Brock M; Kalofonos HP
    Sci Rep; 2018 Mar; 8(1):5259. PubMed ID: 29588475
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Chaszczewska-Markowska M; Kosacka M; Chryplewicz A; Dyła T; Brzecka A; Bogunia-Kubik K
    Anticancer Res; 2019 Jun; 39(6):3269-3272. PubMed ID: 31177178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variant of BCL3 gene is strongly associated with five-year survival of non-small-cell lung cancer patients.
    Dimitrakopoulos FI; Antonacopoulou AG; Kottorou A; Marousi S; Koukourikou I; Kalofonou M; Panagopoulos N; Scopa C; Dougenis D; Papadaki H; Papavassiliou AG; Kalofonos HP
    Lung Cancer; 2015 Sep; 89(3):311-9. PubMed ID: 26122346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-related single-nucleotide polymorphism of XPO5 is strongly correlated with the prognosis and chemotherapy response in advanced non-small-cell lung cancer patients.
    Geng JQ; Wang XC; Li LF; Zhao J; Wu S; Yu GP; Zhu KJ
    Tumour Biol; 2016 Feb; 37(2):2257-65. PubMed ID: 26358254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA Repair Gene Polymorphisms in Relation to Non-Small Cell Lung Cancer Survival.
    Su Y; Zhang H; Xu F; Kong J; Yu H; Qian B
    Cell Physiol Biochem; 2015; 36(4):1419-29. PubMed ID: 26159902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome P450 1B1 (CYP1B1) polymorphisms are associated with clinical outcome of docetaxel in non-small cell lung cancer (NSCLC) patients.
    Vasile E; Tibaldi C; Leon GL; D'Incecco A; Giovannetti E
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1189-94. PubMed ID: 25504507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer.
    Pérez-Ramírez C; Cañadas-Garre M; Alnatsha A; Molina MÁ; Robles AI; Villar E; Delgado JR; Faus-Dáder MJ; Calleja-Hernández MÁ
    Surg Oncol; 2017 Sep; 26(3):278-285. PubMed ID: 28807247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The associations of TERT-CLPTM1L variants and TERT mRNA expression with the prognosis of early stage non-small cell lung cancer.
    Chen Z; Wang J; Bai Y; Wang S; Yin X; Xiang J; Li X; He M; Zhang X; Wu T; Xu P; Guo H
    Cancer Gene Ther; 2017 Jan; 24(1):20-27. PubMed ID: 27982019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of ERCC1-C118T and -C8092A polymorphisms with lung cancer risk and survival of advanced-stage non-small cell lung cancer patients receiving platinum-based chemotherapy: a pooled analysis based on 39 reports.
    Xu TP; Shen H; Liu LX; Shu YQ
    Gene; 2013 Sep; 526(2):265-74. PubMed ID: 23727606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of CD44 Gene Polymorphism with Survival of NSCLC and Risk of Bone Metastasis.
    Liu Y; Qing H; Su X; Wang C; Li Z; Liu S
    Med Sci Monit; 2015 Sep; 21():2694-700. PubMed ID: 26356590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional polymorphisms in PD-L1 gene are associated with the prognosis of patients with early stage non-small cell lung cancer.
    Lee SY; Jung DK; Choi JE; Jin CC; Hong MJ; Do SK; Kang HG; Lee WK; Seok Y; Lee EB; Jeong JY; Shin KM; Yoo SS; Lee J; Cha SI; Kim CH; Park JY
    Gene; 2017 Jan; 599():28-35. PubMed ID: 27838455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Influence of polymorphisms of VEGFR2 on clinical outcomes and safety of advanced non-small-cell lung cancer treated by first line Bevacizumab plus chemotherapy regimens].
    Fan HJ; Yuan J; Wu JJ; Jia YX; Ma YH; Li XY
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(2):99-104. PubMed ID: 30669746
    [No Abstract]   [Full Text] [Related]  

  • 13. Association between genetic variants in pre-microRNAs and survival of early-stage NSCLC.
    Hong MJ; Choi YY; Jang JA; Jung HJ; Lee SY; Lee WK; Yoo SS; Lee J; Cha SI; Kim CH; Lee E; Jeon HS; Son JW; Park JY
    J Thorac Oncol; 2013 Jun; 8(6):703-10. PubMed ID: 23470291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of ERCC2 haplotype-tagging single nucleotide polymorphisms in patients with unresectable non-small cell lung cancer treated with first-line platinum-based chemotherapy.
    Kim SH; Lee GW; Lee MJ; Cho YJ; Jeong YY; Kim HC; Lee JD; Hwang YS; Kim IS; Lee S; Oh SY
    Lung Cancer; 2012 Sep; 77(3):578-84. PubMed ID: 22608006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of genetic variants in advanced non-small cell lung cancer: a genome-wide association study.
    Lee Y; Yoon KA; Joo J; Lee D; Bae K; Han JY; Lee JS
    Carcinogenesis; 2013 Feb; 34(2):307-13. PubMed ID: 23144319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XPG polymorphisms are associated with prognosis of advanced non-small cell lung cancer treated with platinum-based doublet chemotherapy.
    Zou HZ; Zhao YQ
    Genet Mol Res; 2015 Jan; 14(1):500-6. PubMed ID: 25729984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms in glycolytic pathway are associated with the prognosis of patients with early stage non-small cell lung cancer.
    Lee SY; Jin CC; Choi JE; Hong MJ; Jung DK; Do SK; Baek SA; Kang HJ; Kang HG; Choi SH; Lee WK; Seok Y; Lee EB; Jeong JY; Shin KM; Cho S; Yoo SS; Lee J; Cha SI; Kim CH; Lee YM; Lee IK; Jheon S; Park JY
    Sci Rep; 2016 Oct; 6():35603. PubMed ID: 27767175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of p53 codon 72 polymorphism and MDM2 SNP309 with clinical outcome of advanced nonsmall cell lung cancer.
    Han JY; Lee GK; Jang DH; Lee SY; Lee JS
    Cancer; 2008 Aug; 113(4):799-807. PubMed ID: 18618574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influence of apatinib and VEGFR2-906T>C polymorphism on clinical outcomes of advanced non-small cell lung cancer patients].
    Zhao RH; Zhou YN; Li H; Li R; Zhang WJ; Zong H
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(2):105-110. PubMed ID: 30669747
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic variants in genes of tricarboxylic acid cycle key enzymes are associated with prognosis of patients with non-small cell lung cancer.
    Guo X; Li D; Wu Y; Chen Y; Zhou X; Wang X; Huang X; Li X; Yang H; Xing J
    Lung Cancer; 2015 Feb; 87(2):162-8. PubMed ID: 25576295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.